{"id":"W2332844714","doi":"10.1097/md.0000000000000198","title":"Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Medicine","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"FOLFIRINOX; Medicine; Irinotecan; Oxaliplatin; Neoadjuvant therapy; Surgery; Concomitant; Adenocarcinoma; Radiology; Internal medicine; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005358564,0.0001372118,0.0002569778,0.0002596425,0.0001619096,0.0003126274,0.0001481975,0.0001248202,0.0002568602],"category_scores_gemma":[0.001121923,0.0001003049,0.0002471954,0.0003065349,0.0002218606,0.0002030179,0.0001901178,0.0001953727,0.00009089457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002574796,"about_ca_system_score_gemma":0.0002495502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002577048,"about_ca_topic_score_gemma":0.0005295209,"domain_scores_codex":[0.9997391,0.0001250265,0.00004205328,0.00002860961,0.00004050528,0.00002460394],"domain_scores_gemma":[0.9994047,0.0001751136,0.0002183639,0.00004245116,0.000043043,0.0001164113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004677708,0.0004690437,0.8387758,0.0002640841,0.0001154539,0.005501228,0.0003016143,0.001067673,0.03899358,0.00006953919,0.0002568034,0.1095076],"study_design_scores_gemma":[0.0001349439,0.01504163,0.9296443,0.00007849186,0.0002187258,0.02638905,0.0005752455,0.002031346,0.0213212,0.0001044249,0.004438611,0.00002196697],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981287,0.001435688,0.0001813282,0.00001875741,0.000003718622,0.000005417622,0.00001290452,0.000005753553,0.0002077057],"genre_scores_gemma":[0.9990672,0.0005386975,0.0002787321,0.00001983787,0.000007668156,0.000003634412,0.00003914892,0.000001457077,0.00004366882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005358564,"threshold_uncertainty_score":0.002833962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02479493500741469,"score_gpt":0.3370445509532141,"score_spread":0.3122496159457994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}